These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment. Colebunders R; Dohmen S; Van de Velde A; Pelgrom J; Hermans P Acta Clin Belg; 2001; 56(5):321-2. PubMed ID: 11770227 [No Abstract] [Full Text] [Related]
4. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response. Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333 [TBL] [Abstract][Full Text] [Related]
5. Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection. Spina M; Gabarre J; Fasan M; Vaccher E; Tirelli U AIDS; 2000 Jul; 14(10):1457-8. PubMed ID: 10930165 [No Abstract] [Full Text] [Related]
6. AIDS-related systemic non-Hodgkin's lymphoma at a large community program. Vilchez RA; Kozinetz CA; Jorgensen JL; Kroll MH; Butel JS AIDS Res Hum Retroviruses; 2002 Mar; 18(4):237-42. PubMed ID: 11860669 [TBL] [Abstract][Full Text] [Related]
7. Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma. Toffoli G; Corona G; Cattarossi G; Boiocchi M; Di Gennaro G; Tirelli U; Vaccher E Ann Oncol; 2004 Dec; 15(12):1805-9. PubMed ID: 15550586 [TBL] [Abstract][Full Text] [Related]
8. [AIDS and non-Hodgkin's lymphoma: initial cardiac manifestations of highly malignant B-cell lymphoma 18 years after HIV infection]. Sturm A; Noppeney R; Reimer J; Ross B; Baumgart D; Sundermann T; Sadony V; Gerken G Dtsch Med Wochenschr; 2001 Mar; 126(13):364-6. PubMed ID: 11332231 [TBL] [Abstract][Full Text] [Related]
9. Current status of the treatment of HIV-associated lymphoma. Kaplan LD Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156 [No Abstract] [Full Text] [Related]
10. Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). Hentrich M; Hoffmann C; Mosthaf F; Müller M; Siehl J; Wyen C; Hensel M; ; Ann Hematol; 2014 Jun; 93(6):913-21. PubMed ID: 24807241 [TBL] [Abstract][Full Text] [Related]
11. [HIV-related multiple non-Hodgkin lymphomas]. Gotoh M; Kitahara T; Iguchi T; Izumi M; Mukai K; Ohyashiki K Rinsho Ketsueki; 2008 Nov; 49(11):1552-5. PubMed ID: 19047787 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus DNA in serum in a HIV-infected patient during development and treatment of non-Hodgkin's lymphoma. Fleisch F; Reinhart WH; Brand B; Berger C Swiss Med Wkly; 2005 Apr; 135(17-18):263-5. PubMed ID: 15965829 [TBL] [Abstract][Full Text] [Related]
13. Angiotropic B-cell lymphoma with telangiectasia, accompanied by panniculitic formation. Nishiyama H; Tanei R; Motegi T; Ohta M; Sawabe M J Dermatol; 2004 Dec; 31(12):1032-5. PubMed ID: 15801271 [TBL] [Abstract][Full Text] [Related]
14. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass. Ab Hamid S; Wastie ML Singapore Med J; 2008 Mar; 49(3):e73-5. PubMed ID: 18362991 [TBL] [Abstract][Full Text] [Related]
15. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771 [TBL] [Abstract][Full Text] [Related]
16. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma. Miles SA; McGratten M J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386 [No Abstract] [Full Text] [Related]
17. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005 [TBL] [Abstract][Full Text] [Related]
18. Pioneering cord blood transplantation in relapsed/refractory HIV-related lymphoma: a case study with concurrent intramuscular antiretroviral therapy. Yokota T; Kurosawa S; Yoshimura Y; Bingo M; Yamaguchi T; Takada Y; So Y; Miyata N; Nakayama H; Sakurai A; Sato K; Ito C; Aisa Y; Nakazato T Int J Infect Dis; 2024 Sep; 146():107124. PubMed ID: 38838848 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M; Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120 [TBL] [Abstract][Full Text] [Related]
20. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy. Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]